Angiomatous is a medical descriptor meaning “rich in blood vessels” or “resembling an angioma,” and it shows up across a surprisingly wide range of pathology reports, from brain tumors to nasal polyps to veterinary diagnoses. When a pathologist labels a growth angiomatous, they are flagging that the tissue contains an unusually dense network of blood vessels, which can change everything from the way the lesion looks on imaging to how a surgeon approaches removing it. The term itself is not a diagnosis but a qualifying adjective, and understanding what it implies in each context helps make sense of what can otherwise feel like impenetrable medical jargon.
What the Term Actually Tells You
At its core, calling something angiomatous means the tissue sample is packed with blood vessels of varying sizes. These vessels can range from tiny capillary-like channels to large, dilated spaces filled with blood. The cells lining those vessels, called endothelial cells, may be growing more actively than normal, and the overall architecture of the tissue is dominated by this vascular component rather than by the cell type you would usually expect to see. A pathologist examining a slice of tissue under a microscope might note proliferating vessels of different calibers mixed in with fat, connective tissue, or tumor cells, depending on where the sample came from.
Reactive angiomatous changes can also occur. In those situations, blood vessel overgrowth is not driven by a tumor but by the body’s own response to injury, infection, or blood flow disruption. A classification of these reactive patterns notes that they involve overgrowth of endothelial cells and supporting cells, sometimes arranged in lobular clusters and sometimes spread diffusely through the tissue.1PubMed. Cutaneous reactive angiomatoses: patterns and classification of reactive vascular proliferation So the word angiomatous does not automatically mean cancer, or even a true tumor. It describes the tissue’s appearance, and the clinical meaning depends entirely on where it is found.
Angiomatous Meningiomas
One of the most commonly encountered uses of the term in clinical medicine involves meningiomas, the slow-growing tumors that arise from the membranes surrounding the brain and spinal cord. Angiomatous meningioma is a rare subtype classified as WHO grade I, meaning it is considered low-grade and generally benign.2PubMed Central. Angiomatous meningioma with bizarre nuclei: A case report What sets it apart from a typical meningioma is the sheer density of blood vessels running through the tumor. Under the microscope, the tumor shows abundant blood vessels alongside at least some classic meningioma-type cells.3PubMed Central. Clinical characteristics and treatment of angiomatous meningiomas: a report of 27 cases
In a series of 27 patients treated at a single institution, the gender split was nearly even, with 14 men and 13 women.4PubMed Central. Clinical characteristics and treatment of angiomatous meningiomas: a report of 27 cases That roughly equal distribution is itself a bit unusual, because meningiomas as a whole are considerably more common in women.
A Distinctive Genetic Fingerprint
The genetics of angiomatous meningiomas turn out to be genuinely different from those of ordinary meningiomas. Most meningiomas carry a loss of genetic material on chromosome 22, specifically involving the NF2 gene. Angiomatous meningiomas break this rule. Instead of losing chromosomes, they tend to gain extra copies of whole chromosomes, a pattern called polysomy. In one study, every single angiomatous meningioma examined showed gains of chromosome 5, and about nine out of ten also had gains of chromosome 20; none showed the chromosome 22 loss typical of other meningiomas.5PubMed. Multiple Whole Chromosomal Gains Define Angiomatous Meningiomas and Are Absent From the Tumor Vasculature A separate analysis confirmed that polysomies, especially involving chromosomes 5, 13, and 20, appeared in the vast majority of cases.6PubMed Central. Angiomatous meningiomas have a distinct genetic profile with multiple chromosomal polysomies including polysomy of chromosome 5
This genetic signature is useful because it lets pathologists distinguish a true angiomatous meningioma from other blood-vessel-rich tumors that might look similar under the microscope. Interestingly, microcystic meningiomas, another uncommon subtype, share some of these same chromosomal gains, suggesting a possible biological overlap between the two.7Neuro-Oncology Advances. Identification of shared genomic aberrations between angiomatous and microcystic meningiomas
Swelling Around the Tumor
One quirk of angiomatous meningiomas that catches clinicians’ attention is the amount of brain swelling, called peritumoral edema, they can cause. Despite being low-grade, these tumors tend to produce far more surrounding edema than other grade I meningiomas. A study comparing edema across meningioma subtypes found that uncommon grade I variants including the angiomatous type had significantly higher edema indices than both common grade I types and even higher-grade (grade II and III) meningiomas. The most extreme cases of edema were all seen in uncommon grade I subtypes like the angiomatous type.8PubMed. Factors affecting peritumoral brain edema in meningioma: special histological subtypes with prominently extensive edema This means that on a brain scan, an angiomatous meningioma can look more alarming than it actually is, because the surrounding swelling makes it appear aggressive even though the underlying tumor biology is benign.
Treatment Outcomes
Surgical removal is the standard treatment for angiomatous meningiomas. In a multicenter study tracking 58 patients over 15 years, the median time before any recurrence was about 103 months, or just over eight and a half years. Recurrence was linked to how completely the tumor could be removed and where it was located.9PubMed. Intracranial angiomatous meningiomas: A 15-year, multicenter study When recurrences did happen, a second surgery was performed successfully in all cases with no further regrowth afterward. In a smaller series, one patient who had an incomplete resection and received no radiation therapy developed a recurrence within five years.10PubMed Central. Clinical characteristics and treatment of angiomatous meningiomas: a report of 27 cases Overall, the prognosis for this subtype is favorable when surgical removal is thorough.
Angiomatous Nasal Polyps
Outside the brain, one of the most clinically significant uses of the term is in the nose and sinuses. An angiomatous nasal polyp is the rarest type among nasal polyps and can be surprisingly dramatic in its presentation. Patients often show up with a mass filling the nasal cavity, sometimes extending into surrounding structures, causing severe nasal obstruction and nosebleeds.11PubMed Central. Massive Angiomatous Nasal Polyp Mimicking Nasopharyngeal Angiofibroma
The proposed mechanism behind these polyps is mechanical rather than neoplastic. A nasal polyp on a stalk can get squeezed at narrow points such as the sinus opening or the back of the nasal passage. That compression chokes off the blood vessels within the polyp, causing the veins to swell, blood to stagnate, and tissue to become oxygen-starved. Over time, the body responds by growing new blood vessels into the damaged tissue and laying down scar tissue around them.12PubMed Central. The clinicopathological features of sinonasal angiomatous polyps The end result is a polyp densely packed with blood vessels, which earns it the angiomatous label. This process of repeated injury and repair also explains why these polyps can erode into surrounding bone over time.
Distinguishing Polyps from More Serious Growths
Because angiomatous nasal polyps are vascular and can be large, they are sometimes confused on imaging with angiofibromas, which are benign but much more surgically challenging tumors found mainly in adolescent boys. However, angiomatous polyps grow differently on CT scans and have a distinct appearance on angiography. Critically, they are also much easier to remove surgically than true angiofibromas.13PubMed. The angiomatous polyp and the angiofibroma: two different lesions Getting the distinction right matters for treatment planning, since the surgical approach, expected blood loss, and follow-up needs differ considerably between the two.
Angiomatoid Fibrous Histiocytoma
Another growth that borrows the angiomatous concept, though with a slightly modified name, is angiomatoid fibrous histiocytoma. This is an uncommon soft-tissue tumor most often found in children and young adults, typically appearing in the limbs or trunk.14Journal of Clinical Pathology. Angiomatoid fibrous histiocytoma including cases with pleomorphic features analysed by fluorescence in situ hybridisation The “angiomatoid” part of its name refers to the large blood-filled spaces found within the tumor, which are not actually true blood vessels but pseudovascular cavities. These spaces can be dramatic enough to dominate the tumor’s appearance, surrounded by sheets of spindle-shaped tumor cells and often cuffed by lymphoid tissue on the outside.15PubMed. Angiomatoid fibrous histiocytoma: unusual sites and unusual morphology
The distinction between “angiomatous” and “angiomatoid” is worth noting. Angiomatous means the tissue genuinely contains abundant blood vessels. Angiomatoid means the tissue looks like it has blood vessels but the spaces are actually pseudovascular, essentially pools of blood that have accumulated in spaces not lined by proper vessel walls. Pathologists care about this difference because it points toward different diagnoses and different tumor biology.
Angiomatosis as a Broader Condition
When the vascular overgrowth is not confined to a single mass but spreads diffusely through multiple tissue types, the condition is called angiomatosis. This is distinct from a localized angioma or angiomatous tumor. Angiomatosis is a diffuse vascular process that can clinically mimic a hemangioma or vascular malformation and typically involves multiple tissues at once. Under the microscope, it shows vessels of varying sizes mixed with abundant fat tissue.16PubMed Central. Angiomatosis: A Rare Vascular Proliferation of Head and Neck Region Angiomatosis is rare and can be difficult to diagnose because it does not respect normal tissue boundaries the way a discrete tumor would.
Hemangiomatous Ameloblastoma
In the jaw, there is an exceedingly rare variant of ameloblastoma, a type of odontogenic (tooth-related) tumor, that earns the angiomatous or hemangiomatous label. This variant features the expected odontogenic epithelial islands of a standard ameloblastoma but with an extensive network of blood-vessel-filled channels running through it.17PubMed Central. Mandibular Hemangiomatous Ameloblastoma: A Case Report and Literature Review On standard CT imaging, a hemangiomatous ameloblastoma can resemble a fibro-osseous lesion rather than a conventional ameloblastoma, while MRI may suggest a vascular mass instead.18Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics. Hemangiomatous ameloblastoma of the mandible: report of a case and review of the literature The mismatch between imaging modalities can lead clinicians down the wrong diagnostic path, which is why biopsy is essential. Only a handful of these cases have ever been documented, so the long-term behavior and prognosis remain unclear, though they are thought to behave similarly to conventional ameloblastomas.
Why Vascularity Matters for Surgery
Across all these contexts, the reason clinicians and pathologists care so much about the angiomatous label is practical: blood-vessel-rich growths bleed more during surgery. For highly vascular tumors, preoperative embolization, where a radiologist threads a catheter into the tumor’s feeding arteries and blocks them with tiny particles or a liquid agent, can dramatically reduce intraoperative blood loss. In one case of a highly vascular brain tumor, embolization converted a blood-rich mass into an essentially bloodless one, allowing safe surgical removal the next day.19PubMed. Complete preoperative embolization of hemangioblastoma vessels with Onyx 18
The evidence for this approach extends to other body sites as well. For blood-vessel-heavy spinal tumors, particle-based embolization before surgery cut median blood loss from about 4,350 mL without any embolization down to roughly 1,800 mL.20American Journal of Neuroradiology. Hypervascular Spinal Tumors: Influence of the Embolization Technique on Perioperative Hemorrhage For nasopharyngeal angiofibromas with advanced staging, preoperative embolization significantly reduced bleeding during surgery as well.21PubMed. Efficacy of Preoperative Transcatheter Arterial Embolization for Nasopharyngeal Angiofibroma: A Comparative Study This does not mean every angiomatous lesion needs embolization, as small, accessible tumors can often be removed safely without it, but for large or deep-seated growths, cutting off the blood supply first can be a genuine lifesaver.
How Pathologists Confirm Vascular Identity
When a pathologist suspects a lesion is angiomatous, they often need to confirm that the cells lining those vessel-like spaces are truly endothelial, the cell type that lines blood vessels. This is done with immunohistochemical staining, where antibodies are applied to tissue slides to light up specific proteins. Among the markers commonly used, CD31 has emerged as the most reliable: it stains both well-formed vessels and poorly developed vascular structures, and it almost never gives a false positive in non-vascular tumors.22PubMed. Different immunoreactivity of endothelial markers in well and poorly differentiated areas of angiosarcomas Other markers like CD34 can miss poorly differentiated vascular cells, and some stain non-vascular tissues too freely, making them less useful on their own.
In veterinary pathology, similar markers confirm vascular identity. In a case of diffuse splenic haemangiomatosis in a dog, pathologists used CD34 and von Willebrand factor to verify that the cells lining the abnormal vascular spaces were endothelial, while a negative stain for podoplanin ruled out a lymphatic rather than blood-vessel origin.23Veterinary Record Case Reports. A case of isolated diffuse splenic haemangiomatosis in a dog The logic is the same across species: you need to prove the vessels are real before diagnosing a lesion as angiomatous.
Vascular Tumors and Blood-Trapping Complications
Certain vascular tumors, particularly those seen in infants, can trigger a dangerous complication in which the abnormal blood vessels essentially trap platelets and clotting factors within the tumor, depleting them from the rest of the body. This syndrome, known as Kasabach-Merritt phenomenon, features dangerously low platelet counts, consumption of fibrinogen, elevated breakdown products from clotting, and rapid tumor growth.24PubMed Central. Kasabach-Merritt Phenomenon: Classic Presentation and Management Options It occurs specifically with kaposiform hemangioendothelioma and tufted angioma, two rare vascular tumors, and not with the more common infantile hemangioma despite older literature sometimes conflating the two.25PubMed. Recent advances in the pathobiology and management of Kasabach-Merritt phenomenon
Treatment has evolved in recent years. Counterintuitively, platelet transfusions can actually worsen the condition by feeding more platelets into the tumor’s trap. Instead, current approaches combine antiplatelet medications with chemotherapy, particularly vincristine, and deliberately withhold platelet transfusions unless absolutely necessary. This combination has shown strong response rates without requiring steroids.26PubMed. Recent advances in the pathobiology and management of Kasabach-Merritt phenomenon The lesson for anyone encountering the angiomatous label in a pediatric setting is that the type of vascular tumor matters enormously for predicting complications and choosing treatment.
The Angiomatous Label in Veterinary Medicine
Veterinarians encounter angiomatous and related vascular lesions frequently, particularly in the spleen of dogs. Among splenic masses submitted for pathology, a large study found that the most common diagnosis was hyperplasia (about 41% of cases), while the most common cancer was hemangiosarcoma, accounting for roughly one in five splenic masses.27PubMed Central. Pathological Characterization and Risk Factors of Splenic Nodular Lesions in Dogs (Canis lupus familiaris) True angiomatosis of the spleen in dogs is quite rare: a population-based study of 439 vascular tumors and tumor-like lesions in dogs over nearly a decade found only a single case of angiomatosis.28PubMed. Canine vascular neoplasia–a population-based clinicopathologic study of 439 tumours and tumour-like lesions in 420 dogs
As in human medicine, the diagnostic challenge for veterinary pathologists is distinguishing benign vascular overgrowth from malignant hemangiosarcoma, which behaves aggressively and metastasizes readily. The same immunohistochemical markers used in human pathology, including CD31 and CD34, help veterinary pathologists make this distinction and guide treatment decisions for pet owners facing a difficult prognosis conversation.
Retinal Angiomatous Proliferation
The retina is another site where the angiomatous label appears, most commonly in the context of age-related macular degeneration. Retinal angiomatous proliferation refers to new blood vessel growth that originates within the retina itself, rather than underneath it as occurs in the more familiar “wet” form of macular degeneration. In histopathological examination of affected eyes, researchers have found that this abnormal vessel growth forms as a mass that expresses vascular endothelial growth factor (VEGF), accompanied by migration of immune cells and signs of oxygen deprivation in the surrounding tissue.29PubMed. Clinicopathological findings of retinal angiomatous proliferation These findings helped establish that the condition is driven by local oxygen starvation, which triggers the retina to produce signals that spur blood vessel growth. Understanding this mechanism has been important for the development of anti-VEGF injections, the mainstay treatment for wet macular degeneration and its angiomatous variant.